Explore Raise Eng - -



Slumber Bump, LLC (SB)

St. George, Utah Healthcare



Slumber Bump (SB)

St. George, Utah Healthcare


$0

0% target $50,000 0 investors
to go
$

Company Highlights:
  • Founded by Dr. Shad L. Morris, a sleep medicine specialist
  • Dr. Shad L. Morris is Head Dentist in NFLPA Meetings
  • Aiming at creating happier, healthier lives for people who snore
  • An affordable, simple and effective product which allow our patients to sleep comfortably


About Slumber Bump, LLC

slumberBUMP™ was invented by Dr. Shad Morris, DMD from Premier Sleep Solutions.  slumberBUMP™ is a medical device that, when worn properly, helps people who snore to sleep on their side, rather than their back; this is known as sleep positioning. Sleeping on your back is the number cause of snoring today. There have been many makeshift ways to help a person not sleep on their back, the most common was by sewing a tennis ball in the back of a shirt to prevent rolling over.

We started as an oral appliance therapy office and witnessed the dramatic and very personal transformations our patients experienced with better sleep. They were happier, had more energy, functioned better at work, learned better, were safer drivers, enjoyed healthier relationships, spent less time and money at the doctor, and so much more.*

Anxious to help every patient, we looked for additional ways to restore sleep and learned what a powerful role sleep position plays in a good night's rest. We were intrigued that something as simple as side-sleeping could stop snoring.

Dr. Shad Morris Sets Example for Sleep Dentists Nationally in Former NFL Player Health Assessment

Dr. Shad Morris, DMD, led the dental/sleep apnea team of ASBA Diplomates at the health assessment for former NFL players in Las Vegas, Nevada.

The board-certified sleep physician who worked in collaboration with Dr. Morris was Dr. Cliff Molin. Project Rose provided the sleep testing equipment for the event and was able to provide a home sleep test to every player who was found to be at high risk of sleep apnea. Founded by Earl Campbell and Gary Baxter, Project Rose Sleep Program is a premier sleep program that tests, treats and does research in the field of sleep for better health and wellness outcomes. The initial testing reports from this event found that 93 percent of former players who were tested came back positive for sleep apnea.

David Gergen, CEO of Pro Player Health Alliance (PPHA), was appointed by Andre Collins who is the executive director of the Players Athletes Foundation to oversee the sleep apnea component of the health assessments. Gergen selected a team of sleep dentists who need to meet a number of requirements to participate: They must be Diplomates of the American Sleep and Breathing Academy (ASBA), have a strong community presence and have the capability to treat Medicare patients. Dr. Shad Morris, DMD, led the team of ASBA Diplomates which included Dr. Ronald Rosenbaum, DMD, and Dr. Edward Hobbs, DDS.

Shad has donated time and money to help elderly in his community with holiday church functions for years. He has explained to me that his grandparents forged the way for his future. Although many dentists stay away from Medicare because the reimbursement isn't good and contains so many regulations, Dr. Morris doesn't mind because he believes in doing the right thing and helping those who worked hard to give him the opportunities to thrive today; giving back is the right thing to do. When I interviewed him for the position in December of 2017, he told me it's not about the money it's about successful outcomes, I knew he was the right guy to bring that same attitude to treating members of the NFLPA.

Gergen mentioned Dr. Morris as the perfect candidate to be the sleep dentist for the newly relocated Las Vegas Raiders because of his thousands of successful outcomes.
 

What is slumberBUMP™?

Alternative-Conservative Therapy for Snoring and Sleep Disordered Breathing™
slumberBUMP™ is the leader in Alternative-Conservative Therapy for Snoring and Sleep Disordered Breathing™. Snorers are often told to sleep on their sides rather than on their backs. Here's why: sleeping flat on the back causes the tongue to collapse into the airway, which obstructs breathing and creates those not-so-adorable snoring noises. Side-sleeping is a better position because it keeps the airway open and allows snorers to breathe freely. Changing sleep positions can make a huge difference and be an incredibly easy snoring fix.*

Maintaining a side-sleeping position often requires a little encouragement as we all unconsciously shift positions while we sleep. That's where slumberBUMP™ can help. For those struggling with sleep apnea sleep, positional therapy can help.

The slumberBUMP™ is an ultra-lightweight, breathable sleep belt that trains individuals to sleep comfortably on their side so breathing can return to normal. Featuring an inflatable air pocket, the sleep belt is easily worn around the chest and keeps snorers from rolling over throughout the night. Often, the device only needs to be worn for 30-60 days until side-sleeping feels natural.*

While any new sleep position can take a little time to adjust, we suggest experimenting with different positions until you find your sweet spot.  

A Little History of slumperBUMP™

Fourteen years ago, Shad L. Morris, DMD, had a successful general dentistry practice in Cedar City, Utah, but he wanted more. A friend and colleague had a TMJ/sleep practice, and Morris took his staff to the practice to see how it operated.

Upon his return, Morris saw a great business opportunity and a real chance to help people. Almost immediately, he discovered that one of his friends and patients, a 62-year-old man named Bob, had sleep apnea. Bob’s wife joked that she simply had to jab him in the ribs and get him to turn on to his side to avoid the sleep stoppages caused by sleep apnea.

“I had been learning about the seriousness of sleep apnea,” says Dr. Shad L. Morris. “Bob was well off with millions of dollars so money for treatment was not a problem, but I said, ‘Hey, I’m learning about these oral appliances, so let me make you one for free’ just to try it. He said ‘no’ and a couple months later, Bob went to sleep and never woke up. With everything to live for, he died from sleep apnea at the age of 62.”

The death sent Morris on a mission, bringing him to where he is today as the owner of three sleep-focused practices and inventor of the slumberBUMP, a device to help users sleep comfortably on their side. “When you sleep on your side, it allows your jaw to rest in a comfortable position that naturally keeps your airway open and clear all night,” Morris says.
 
"The slumberBUMP increases the effectiveness of CPAP, oral appliances, or even surgery."
- Dr. Shad L. Morris

Prior to inventing the slumberBUMP and pursuing sleep medicine full time, Morris attempted to combine traditional restorative dentistry with a sleep practice. In the small Utah town of Cedar City, he worked with one boarded sleep physician, gaining experience with sleep apnea. “It was hard to do both the medical and dental,” Morris says. “Finally, I sold two dental practices and opened Premiere Sleep Solutions in 2012 to treat only snoring and sleep apnea.”

With the help of a business partner, Morris figured out the crucial medical billing aspects and got the practice in St. George humming along particularly well with excellent profitability. Additional practices followed (Utah and Las Vegas) with Morris’ expertise leading him to a prime situation, partnered with a sleep physician for in-network referrals.
   


   
“It’s plain as day on the sleep study, when patients are on their back, their apnea and snoring is three to five times worse than on their sides. A lot of patients do not need anything other than staying off their backs. It also increases the effectiveness of my oral appliances. The idea is to take this product to the world, as a stand alone device or in combination with other sleep apnea therapies.
- Dr. Shad L. Morris


Our Mission

  • to help increase the quality of life, the quantity of life, and relationships
  • to nurture the slumberBUMP and increase its exposure in America and beyond

We noticed you like to sleep. If you have a slumber buddy that snores like a pig, then SlumberBUMP may help you and your bump buddy get a better night sleep.
 




Is slumberBUMP™ effective for everyone?
The slumberBUMP™ positional sleep trainer is effective for about 8 out of 10 people who are mild to moderate snorers. It’s also highly effective to be used along with other treatments like CPAP Therapy or Oral Appliance Therapy. slumberBUMP™ is most effective for those who are positionally dependent snorers…meaning, if you mostly snore while you sleep on your back, but stop when you roll over, slumberBUMP™ should work for you*.
 
What should I expect when I start using my slumberBUMP™?
Just like getting a new pillow, sleeping with the slumberBUMP™ takes a little getting used to. For some people who aren’t used to sleeping on their sides, it can causes some muscle soreness and aches as your body adjusts to a new sleeping position. However, most people find that after a couple of weeks they are sleeping better than before.
 
Do I have to use the slumberBUMP™ forever?
Do I have to use the slumberBUMP™ forever?
Nope. You sure don't. SlumberBUMP™ is a positional sleep trainer. The results can be permanent. If used regularly, most people only need to sleep with the slumberBUMP™ for 30 - 60 days. After that, you will have learned to sleep on your side. After the new habits have been formed, most people will continue sleeping on their side, even without the slumberBUMP™. Many people will still take their slumberBUMP™ with them when they travel since new beds and pillows can change the way you sleep. If you ever find yourself sleeping on your back again, simply use the slumberBUMP™ for a few weeks to retrain your body to sleep on its side*.

About the Founder

Dr. Shad L. Morris
Founder & CEO
  
Dr. Shad Morris, DMD is a sleep medicine specialist in Saint George, UT and has been practicing for 17 years. He graduated from Southern Illinois University School Of Dental Medicine in 2001 and practices sleep medicine.
 
As a member of the American Academy of Dental Sleep Medicine for the past seven years, Dr. Shad Morris has treated sufferers of sleep apnea, CPAP intolerance, and snoring. Overwhelmingly, what he saw in his patients was a shared sense of frustration.
 
Dr. Shad L. Morris co-founded Premier Sleep Solutions in 2002, when Dr. Morris began observing the toll that obstructive sleep apnea (OSA) was taking on the oral health of his patients. In particular, a friend and dental patient whom he treated suddenly passed away in his sleep from obstructive sleep Apnea one night due to not wearing his CPAP.
 
Dr. Morris decided he wanted to help save lives by treating OSA. The development of slumberBUMP™, a device helps OSA patients to sleep comfortably on their side, is another important milestone in the journey of fighting OSA. Today, apart from being the founder and inventor of inventor of the slumberBUMP™, Dr. Morris is also the owner of three sleep-focused practices.
 
Dr. Morris's involvement in sleep medicine turned from primarily screening for sleep apnea to now having very close relationships with sleep physicians and allied health professionals in the community in treating this disease.
 
Dr. Shad Morris Chosen as Head Dentist in NFLPA Meeting
Dr. Shad Morris was the lead sleep dentist at the NFLPA’s PAF/Living Heart Foundation Health Screening at the NFLPA Annual Meeting in Las Vegas. Dr. Morris impressed everyone who was involved with his dedication, professionalism and attention to detail as well as his demonstration of digital scanners.
 
 
When asked why Dr. Morris was selected to be the point man for the health assessment, David Gergen, The CEO of the PPHA, David Gergen said, “Shad has donated time and money to help elderly in his community with holiday church functions for years. He has explained to me that his grandparents forged the way for his future. Although many dentists stay away from Medicare because the reimbursement is extremely low and contains so many regulations, Dr. Morris doesn’t mind because he believes in doing the right thing and helping those who worked hard to give him the opportunities to thrive today; he said giving back is the right thing to do. When I interviewed him for the position in December of 2017, he told me it’s not about the money it’s about successful outcomes. I knew he was the right guy to bring that same attitude to treating members of the NFLPA.”
 
 

Business Strategy


SlumberBUMP™ is the leader in Alternative-Conservative Therapy for Snoring and Sleep Disordered Breathing. Snorers are often told to sleep on their sides rather than on their backs. Here's why: sleeping flat on the back causes the tongue to collapse into the airway, which obstructs breathing and creates those not-so-adorable snoring noises. Side-sleeping is a better position because it keeps the airway open and allows snorers to breathe freely. Changing sleep positions can make a huge difference and be an incredibly easy snoring fix.

Maintaining a side-sleeping position often requires a little encouragement as we all unconsciously
shift positions while we sleep. That's where slumberBUMP™ can help. For those struggling with
sleep apnea sleep, positional therapy can help.

SlumberBUMP™’s mission is to not only improve the quality and quantity of life, but to build and strengthen, as well as to repair relationships with people who often times suffer as much or more as the person with snoring and/or sleep disordered breathing.

We plan to raise funds through a Regulation Crowdfunding offering in which we will issue new
memberships units of Slumber Bump, LLC.

These funds will be used as follows:
● Increased Production of Slumber Bump
● Hiring of Additional Key Leaders and Employees
● Marketing & Educating (US)
● Marketing & Educating (EU, AUS)
● Research and Development
● Accounting and Professional Fees
● Working capital and cash reserves



Marketing Strategy


To kick things off, Slumber Bump, LLC is going to participate in nationwide television show named America’s Real Deal. The hosts of the show are Kevin Harrington and Forbes Ridley. We feel it will be a great way to kick off our marketing plans. The show estimates to give us a nationwide exposure in the US market. We also hope to utilize this opportunity to educate our audience about the seemingly harmless snoring problem and sleep apnea related issues.

Secondly, social media networks are going to be used to spread awareness of our brand. Nowadays, social media are becoming a major factor in direct sales. The company will start using these medias to get direct sales as well as exposure for product branding. Together with expanded online purchasing options, such as purchasing products directly from our videos, we hope to achieve greater sales.

Marketing tools/sources that we can utilize:
● Online advertising on Facebook, Twitter, Youtube, etc.
● Online blog posts
● Newspaper advertising
● Samples at clinics
● Dr. Morris’ personal dental practice


Operational Plan



 			

SWOT Analysis



 			

Human Resources



 			

Social Responsibility



 			

Future Plans


The five-year plan with SlumberBUMP™ is to continue research and development in technology and innovation with other products that will enhance and complement the treatment of snoring and sleep disordered breathing. In the meantime, being able to treat and help make a difference in the lives of hundreds of thousands of millions of people who will be buying the SlumberBUMP™
product. 

The funds raised will be used to market and educate current and future users of SlumberBUMP™. Beginning with the United States, then Europe and Australia where we are currently distributing SlumberBUMP™. Eventually, to the rest of the world. 

Along with further solidifying my team with other essential key leaders and employees that will be needed to handle the exponential growth of the company.


Financial Year Dec-2017
Revenue $145,481
Cost of Good Sold $64,887
Taxes Paid $1,643
Net Income ($22,924)
Total Assets $13,809
Cash & Cash Equivalents $10,209
Accounts Receivable $0
Total Liabilities $0
Short-term Debt $0
Long-term Debt $0

Dividend Policy
The declaration of future dividends by the Company will be subject to the discretion of the Board and applicable laws and will be dependent upon the Company's financial condition and operating results. 

The Company currently intends to retain any future earnings to fund business development and growth, and we do not expect to pay any dividends in the foreseeable future. Therefore, shareholders expecting regular income may find that investing in the Company may not be able to meet their investment objective.
Risk Factors
RISKS RELATING TO OUR BUSINESS

We rely on the leadership and services of our founder and Chief Executive Officer, Dr. Shad L. Morris, and our inability to retain his services could adversely affect our business and financial conditions, operating results and business prospects. 
Dr. Shad L. Morris is our founder and Chief Executive Officer. Dr. Shad L. Morris is the controlling shareholder following the Offering. We believe that Dr. Shad L. Morris, who invented slumberBUMP,  is the driving force for our business growth and brand recognition, on account of his expertise, experience and leadership. Our sustained business growth in the future will continue to depend on the leadership and involvement of Dr. Shad L. Morris. We may not be able to identify and engage a professional as suitable as Dr. Shad L. Morris and may not be able to replace him easily, or at all. 

Our business depends significantly on the reputation of Dr. Shad L. Morris and any negative publicity and allegations in the media against Dr. Shad L. Morris could materially and adversely affect our business and financial conditions, operation results and business prospects. 
Patients may buy our products on account of the reputation of Dr. Shad L. Morris, our founder and Chief Executive Officer, and as such, our brand awareness is, to a certain extent, built upon the reputation of Dr. Shad L. Morris. Therefore any negative publicity of or media coverage about or any other negative impact on the reputation of Dr. Shad L. Morris could have a negative impact on our reputation or brand image, which could in turn materially and adversely affect our business and financial conditions, operating results and business prospects.

We may be unable to price slumberBUMP products at our desired margins as a result of any decrease in our bargaining power or changes in market conditions 
We set prices for our slumberBUMP products primarily based on the estimated costs incurred in the production of a part plus a profit margin that varies depending a number of factors. We periodically review our costs of production and set  prices for our slumberBUMP products. Our ability to set favourable prices at our desired margins and to accurately estimate costs, among other factors, has a material impact on our profitability. We cannot assure you that we will be able to maintain our pricing or bargaining power or that our gross profit margin will not be driven down by market conditions or other factors. In the event that we see higher pressure on pricing due to increasing competition from other manufacturers, continual decrease in prices of our customers’ products in the end market, or if we lose bargaining power due to weaker demand for slumberBUMP products, we may need to lower the prices and margins of our products. Moreover, we may be unable to accurately estimate our costs or pass on all or part of any increase in our costs of production to our customers. As a result, our results of operations could be materially and adversely affected.

If our products are manufactured improperly, our reputation, business, financial condition and results of operation may be materially and adversely affected 
We are exposed to risks inherent in the production, packaging, sale and marketing of our products, such as unsafe, ineffective or defective products, and insufficient or improper labelling of products. If any of these happens, we may be subject to product recall or withdrawal for such products and exposure to lawsuits relating to such products. 

slumberBUMP products are required to meet certain quality standards. However, we cannot eliminate the risk of errors, defects or failure. We may fail to detect or cure quality defects due to a number of factors, many of which are outside our control, including human error or malfeasance by our quality control personnel, tampering by third parties, and quality issues with the raw materials we purchase or produce. Failure to detect quality defects in our products could result in patient injury, product recalls or withdrawals, product returns, licences revocation or fines, or other problems that could seriously harm our reputation and business, expose us to liability, and materially and adversely affect our business, financial condition and results of operations.

We may not be able to adequately protect our intellectual property, which could harm the value of our brands and adversely affect our business and operation.
We may face claims of infringement that could interfere with the use of our proprietary know-how, concepts, technologies, or trade secrets. Defending against such claims may be costly and, if we are unsuccessful, we may be prohibited from continuing to use such proprietary information in the future or be forced to pay damages, royalties or other fees for using such proprietary information, any of which could negatively affect our sales, profitability and prospects.

Defend against third-party allegations of intellectual infringement may be costly 
We may encounter litigation by third parties based on claims that our products or activities infringe the intellectual property rights of others or that we, our employees or consultants have misappropriated the trade secrets of others. It is difficult to predict how such disputes would be resolved. The prosecution and defence of intellectual property rights are costly and will divert management personnel from their normal responsibilities. We may not prevail in any such litigation or proceedings. 
  
The use of our products may lead to injuries and we may face product liability and other claims exposure for which we may not be able to obtain adequate insurance. 
Failure to use our products for their intended purposes, failure to use or care for them properly, or their malfunction, or, in some limited circumstances, even correct use of our products, could result in serious bodily injury. 

In cases of product liability and other claims arising in tort, or claims for indirect and consequential loss, we may become subject to one or more product liability claims that, individually or together, could adversely affect our operations, financial condition and operating results.  These claims could be expensive to defend and require the expenditure of significant resources and we cannot guarantee that our insurance coverage would be sufficient to cover the payment of any potential claim. Any claim brought against us in excess of available insurance coverage, or any claim or product recall that results in significant expense or adverse publicity against us, could have a material adverse effect on our business, operating results and financial condition. 

Our research and development activities may not result in the successful development of new products, applications of existing products, product formulation, or production methods or techniques 
Our future growth and prospects are dependent on our ability to successfully develop new products, applications of existing products, product formulation, or production methods or techniques, which can be affected by many factors beyond our control. These include failure to meet the safety, efficacy or other standards and requirements during testing and clinical trials, or failure to obtain regulatory approvals. We commit substantial efforts, funds and other resources to our research and development. However, the new product development process is complex, uncertain, time-consuming and costly. If our research and development activities do not result in the successful development of any new products, applications of existing products, product formulation, or production methods or techniques, we will not be able to recover the related costs of such research and development activities and will need to write-off the relevant capitalised development costs, which could materially and adversely affect our financial condition and results of operation.

We may not be able to fully comply with regulatory requirements and certain certifications which are material to our business 
slumberBUMP™ is a device designed for helping people who snore to sleep. We cannot guarantee that our products are fully comply with regulatory requirements. In addition, slumberBUMP products, which could be required to obtain certain certifications from local or foreign authorities before it can be sold to retail customers.  We cannot assure you that we will be able to comply with these regulatory requirements and certifications. If this happens, our operations,  business, and our reputation may be adversely affected as a result. To comply with these regulatory requirements and certification, there may be significant additional costs and expenses involved, which may also adversely affect our results of operations.

Dependence on outside manufacturers and suppliers
We depend heavily on various manufacturers and suppliers to manufacture our products and provide raw materials for producing or products. If there is any delay in delivery, or failure to meet our expectations and requirements, our business could be seriously affected. Currently, we rely on outside manufacturers and suppliers for most of our products. In the event that any of our suppliers or manufacturers should become too expensive or suffer from quality control problems or financial difficulties, we would have to find alternative sources, but we cannot guarantee that we can find alternative sources timely or at the same cost level.

Advertising and increased marketing effort may not lead to higher sales or increase in our revenue
To increase public awareness of our business and enhance our brand, one of our business strategies is to advertise and run marketing campaigns on social media and Youtube. Nonetheless, despite our efforts and substantial costs incurred in these marketing effort and advertisements, it may not necessarily lead to higher sales of our products or increase in our revenue. 


We may be unable to efficiently manage our inventory risks
If we fail to manage our inventory effectively, we may be subject to a heightened risk of inventory obsolescence, a decline in inventory values and significant inventory write-offs. High inventory levels may also require us to commit substantial capital resources, preventing us from using that capital for other important purposes. Any of the above may materially and adversely affect our results of operations and financial condition.

Our net cash outflow from operating activities may affect our liquidity
We cannot assure you that we will not experience any period of net cash outflow from operating activities in the future. Our liquidity in the future will to an extent depend on our ability to maintain adequate cash inflows from operating activities primarily generated from our trade and other accounts receivables. Should there be any significant deterioration in the quality of our trade and accounts receivable portfolio, our liquidity and cash flows from operating activities could be materially and adversely affected.

We may not be able to successfully implement our business plan 
Details of our business plan are set out in the section headed “BUSINESS AND ANTICIPATED BUSINESS PLAN” in this offering statement. The successful implementation of our business plan depends on a number of factors including, among others, continued growth of the market for our products in the US and overseas, the availability of funds, market competition and relevant government policies. We cannot assure you that our business plans can be implemented successfully as we have contemplated, or at all. Any delays or failure to successfully implement these business plan could result in the loss or delayed receipt of revenue, an increase in financing costs or the failure to grow our business. Implementing our business plans also involves significant expenses, including sales and marketing costs and the cost of acquiring additional property and equipment. Unexpected expenses could prevent us from implementing our business plan within our budget or at all, which may materially and adversely affect our business, financial condition and results of operations. 

Our implementation of our business plan may result in disproportionate increase in staff costs if there is any failure or delay in implementing any part of the business plan
As disclosed under section headed “BUSINESS AND ANTICIPATED BUSINESS PLAN”, we may recruit additional prospective and/or experienced employees in the coming years. As a result, it is expected our staff costs will increase in order to facilitate our business strategies. In the event that there is a failure or delay in implementing any part of our business plan, there will be a disproportionate increase in staff costs, which will in turn materially and adversely affect our financial performance.

Our sales of slumberBUMP products in the US is subject to seasonality and our results of operations are subject to fluctuations 
Our business is subject to risks associated with seasonality. Sales of our products in the US may also fluctuate during the course of a financial year for a number of other reasons. For example, we may experience higher sales during and after our marketing and promotional campaigns. Therefore, our product sales in the US may fluctuate from period to period, and comparison of sales and operating results between different periods within a single financial year may not be meaningful and should not be relied upon as indicators of our performance. In addition, seasonal consumption patterns may cause our operating results and financial condition relating to our product sales in the US to fluctuate from period to period.

We may be unable to secure additional funds in the future to fund our operations or expansion plans 
Our expansion plans may be altered due to any changes in circumstances, the development of our business, unforeseen contingencies or new opportunities. If our expansion plans change, additional external debt or equity financing may be needed. If we are unable to obtain such funding at all or on acceptable terms, we may be unable to expand our business and our operations will be materially and adversely affected. Our ability to such funding depends on various factors, some of which are beyond our control, such as prevailing condition of the capital market, credit availability, interest rates and the performance of our business. If we are unable to obtain additional funding in a timely manner on terms that are satisfactory to us, our business, results of operations and expansion plan may be materially and adversely affected.

Our historical operating results may not be indicative of future performance, and we may not be able to achieve or sustain the historical level of growth for revenue and profitability
Our historical results and growth may not be indicative of our future performance and we may not be able to sustain our growth at a similar rate in the future. Our revenue, expenses and operating results may vary from period to period in response to a variety of factors beyond our control. In such an event, our historical financial statements may not be comparable with our financial statements for any given future financial period, or as on any given date in the future and as such, our operating results and financial performance may be adversely affected.

  
RISKS RELATED TO THE OFFERING
  
Offering price of the Securities is not an accurate reflection of their value
We cannot assure that the offering price of the Membership Units of our company (the “Securities”) will be an accurate reflection of their value. The offering price of the Securities is arbitrarily determined by us taking into account our prospects, all as assessed by our management.  The offering price should not be regarded as an indication of any future price of the Securities, and bears no relationship to our assets, earnings, net tangible book value, or any other traditional criteria of value.  
  
There has been no representation of investors in the preparation of this offering. We have not obtained an independent opinion on behalf of prospective investors regarding the fairness of the terms on which the Securities are offered hereby.   Prospective investors will be relying on the disclosures set forth herein and the additional materials it refers to directly, and on the business and investment background and experience of themselves and any advisors engaged by them, as the basis for their investment decision.
  


We have the right to, and expect to, issue additional shares or sell stock in isolated transactions
We have the right to, and expect to, issue additional units or sell stock in isolated transactions. Our board of directors has authority, without action or vote of our shareholders. Any such issuance will dilute the percentage of return to Investors. 
  
Restrictions on transferability of securities
Restrictions on transferability of securities will limit the ability of purchasers to transfer their Securities. Specially,  the Securities being offered may not be transferred by any purchaser of such Securities during the one year period beginning when the Securities were issued, unless certain conditions are met, as described in Restrictions on Transfer of the Securities Being Offered on this Form C.
  
The Securities offered hereby will be “restricted securities” within the meaning of the Securities Act and, consequently, will be subject to the restrictions on transfer set forth in the Securities Act and the rules and regulations promulgated thereunder. In addition, the Securities are subject to restrictions on transfer under applicable state securities laws under which such securities are sold in reliance on certain exemptions or under the provisions of certain qualifications. As restricted securities, the securities may not be sold in the absence of registration or the availability of an exemption from such registration requirements.
  
We cannot assure that we will pay dividends.  
We do not currently anticipate declaring and paying dividends to our shareholders in the near future. It is our current intention to apply net earnings, if any, in the foreseeable future to increasing its capital base and marketing.  Prospective investors seeking or needing dividend income or liquidity should therefore not purchase shares of our Membership Units.  We cannot assure that we will ever have sufficient earnings to declare and pay dividends to the holders of our Membership Units, and in any event, a decision to declare and pay dividends is at the sole discretion of our board of directors.
    
You can’t easily resell the securities. 
There are restrictions on how you can resell your securities. More importantly, there is no market for these securities, and there might never be one. It’s unlikely that the company will ever go public or get acquired by a bigger company. That means the money you paid for these securities could be tied up for a long time.
   
Our failure to maintain effective internal controls over financial reporting could have an adverse impact on us.  
We are required to establish and maintain appropriate internal controls over financial reporting.  Failure to establish those controls, or any failure of those controls once established, could adversely impact our public disclosures regarding our business, financial condition or results of operations.   In addition, management’s assessment of internal controls over financial reporting may identify weaknesses and conditions that need to be addressed in our internal controls over financial reporting or other matters that may raise concerns for investors. Any actual or perceived weaknesses and conditions that need to be addressed in our internal control over financial reporting, disclosure of management’s assessment of our internal controls over financial reporting or disclosure of our public accounting firm’s attestation to or report on management’s assessment of our internal controls over financial reporting may have an adverse impact on the price of our Membership Units.


Important:

The securities offered by the issuer here are private placements. You should read the followings before investing in these securities:

Investor Alert: Advertising for Unregistered Securities Offerings (by SEC)

Private Placements - Evaluate the Risks before Placing Them in Your Portfolio (by FINRA)

Informed Investor Advisory: Private Placement Offerings (by NASAA)

More Questions & Answsers (
)
Note:

The information provided is a summary only. Please review the full offering documents (Form C) for a full description of the company and offering.

You can cancel an investment commitment until 48 hours prior to the offering deadline.


to go
Funding Target $50,000
Maximum Target $1,070,000
Pre-money Valuation $5,000,000
Equity Offered 0.99% - 17.63%
Securities Type Membership Units
Regulation Regulation CF
Closing Date 30 Jun 2019
Unit Price $100.00
Units Offered

500 - 10,700
Units Issued After Offering

50,500 - 60,700

Corporate Profile:
Company Name
Slumber Bump, LLC
Jurisdiction of Incorporation
Utah
Date of Incorporation
28 May 2013
Telephone
(866)250-8482
Address
75 South 100 East Ste. 1E
St. George
Utah 84770
USA
URL
Industry
Healthcare
No. of Employees
1
Funding Purpose:

- Increased Production of Slumber Bump
- Hiring of Additional Key Leaders & Employees
- Marketing & Educating (US)
- Marketing & Educating (EU & Australia)
- Research and Development
- Accounting and Professional Fees
- Working capital and cash reserves

Major shareholders:



About Mr. Crowd Crowdfunding One-Stop Service Terms of Use Fees and Charges Privacy Policy Cookie Policy The Mr. Crowd University Contact Us


REGULATION CROWDFUNDING - GENERAL RULES AND REGULATIONS

IMPORTANT LEGAL NOTICE: Ksdaq Inc. owns and operates Mr. Crowd (www.MrCrowd.com), a funding portal (the "Funding Portal") registered with the Securities and Exchange Commission (SEC) and a member of the Financial Industry Regulatory Authority (FINRA) [FINRA Funding Portal Members]. By accessing the Funding Portal and any pages on the Funding Portal, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time without notice or liability. Securities offerings posted on the Funding Portal are limited to Regulation Crowdfunding, Regulation A and Regulation D offerings.
  • Regulation Crowdfunding offerings on the Funding Portal are conducted through Ksdaq Inc.
  • Regulation A and Regulation D offerings on the funding portal are not conducted through Ksdaq Inc.
  • Regulation A and Regulation D offerings are for informational and solicitation of interest (testing the waters) purposes only.
  • Investors must acknowledge and accept the high risks associated with investing in private securities offerings. These risks include holding your investment for periods of many years with limited ability to resell, limited access to periodic reporting, and losing your entire investment. You must have the ability to bear a total loss of your investment without a change in your lifestyle. Funding Portal is only required to conduct limited due diligence on each Issuer and does not in any way give investment advice, provide analysis or recommendations regarding any offering posted on the Funding Portal. Past performance is not indicative of future performance. All investors should make their own determination of whether or not to make any investment in an offering, based on their own independent evaluation and analysis and after consulting with their financial, tax and investment advisors. Prior to making any investment, you will be required to demonstrate your understanding of the speculative nature of investing in such private securities. The securities offered on this Funding Portal can only be marketed in jurisdictions where public solicitation of offerings are permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence. You are strongly advised to consult your legal, tax and financial advisor before investing.

    You can learn more about investing in crowdfunding from the SEC, FINRA or NASAA.

    1000 Corporate Center Drive, Suite 310, Monterey Park, CA 91754


    Copyright © 2018 Ksdaq Inc.